Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 19 December 1997: Vol. 278. no. 5346, pp. 2085 - 2092 DOI: 10.1126/science.278.5346.2085
|
|
Research Articles
Immune Versus Natural Selection: Antibody Aldolases with Enzymic Rates But Broader Scope
Carlos F. Barbas III,
*
Andreas Heine,
Guofu Zhong,
Torsten Hoffmann,
Svetlana Gramatikova,
Robert Björnestedt,
Benjamin List,
James Anderson,
Enrico A. Stura,
Ian A. Wilson,
*
Richard A. Lerner
*
Structural and mechanistic studies show that when the selection
criteria of the immune system are changed, catalytic antibodies that
have the efficiency of natural enzymes evolve, but the catalytic antibodies are much more accepting of a wide range of substrates. The
catalytic antibodies were prepared by reactive immunization, a process
whereby the selection criteria of the immune system are changed from
simple binding to chemical reactivity. This process yielded aldolase
catalytic antibodies that approximated the rate acceleration of the
natural enzyme used in glycolysis. Unlike the natural enzyme, however,
the antibody aldolases catalyzed a variety of aldol reactions and
decarboxylations. The crystal structure of one of these antibodies
identified the reactive lysine residue that was selected in the
immunization process. This lysine is deeply buried in a hydrophobic
pocket at the base of the binding site, thereby accounting for its
perturbed pKa.
The authors are at The Skaggs Institute for Chemical Biology and
the Department of Molecular Biology, The Scripps Research Institute,
10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
*
To whom correspondence should be addressed.
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Structural Basis for D-Amino Acid Transamination by the Pyridoxal 5'-Phosphate-dependent Catalytic Antibody 15A9.
- B. Golinelli-Pimpaneau, C. Luthi, and P. Christen (2006)
J. Biol. Chem.
281, 23969-23977
| Abstract »
| Full Text »
| PDF »
- Breaking the one antibody-one target axiom.
- F. Guo, S. Das, B. M. Mueller, C. F. Barbas III, R. A. Lerner, and S. C. Sinha (2006)
PNAS
103, 11009-11014
| Abstract »
| Full Text »
| PDF »
- Asymmetric Catalysis Special Feature Part II: New mechanistic studies on the proline-catalyzed aldol reaction.
- B. List, L. Hoang, and H. J. Martin (2004)
PNAS
101, 5839-5842
| Abstract »
| Full Text »
| PDF »
- Asymmetric Catalysis Special Feature Part I: Chiral phosphoramide-catalyzed, enantioselective, directed cross-aldol reactions of aldehydes.
- S. E. Denmark and T. Bui (2004)
PNAS
101, 5439-5444
| Abstract »
| Full Text »
| PDF »
- Induced Fit Movements and Metal Cofactor Selectivity of Class II Aldolases: STRUCTURE OF THERMUS AQUATICUS FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE.
- T. Izard and J. Sygusch (2004)
J. Biol. Chem.
279, 11825-11833
| Abstract »
| Full Text »
| PDF »
- Prodrugs of dynemicin analogs for selective chemotherapy mediated by an aldolase catalytic Ab.
- S. C. Sinha, L.-S. Li, G. P. Miller, S. Dutta, C. Rader, and R. A. Lerner (2004)
PNAS
101, 3095-3099
| Abstract »
| Full Text »
| PDF »
- Insights from molecular dynamics simulations into pH-dependent enantioselective hydrolysis of ibuprofen esters by Candida rugosa lipase.
- J. J. James, B. S. Lakshmi, V. Raviprasad, M. J. Ananth, P. Kangueane, and P. Gautam (2003)
Protein Eng. Des. Sel.
16, 1017-1024
| Abstract »
| Full Text »
| PDF »
- Chemically programmed monoclonal antibodies for cancer therapy: Adaptor immunotherapy based on a covalent antibody catalyst.
- C. Rader, S. C. Sinha, M. Popkov, R. A. Lerner, and C. F. Barbas III (2003)
PNAS
100, 5396-5400
| Abstract »
| Full Text »
| PDF »
- Active Site in RrmJ, a Heat Shock-induced Methyltransferase.
- J. Hager, B. L. Staker, H. Bugl, and U. Jakob (2002)
J. Biol. Chem.
277, 41978-41986
| Abstract »
| Full Text »
| PDF »
- A cofactor approach to copper-dependent catalytic antibodies.
- K. M. Nicholas, P. Wentworth Jr., C. W. Harwig, A. D. Wentworth, A. Shafton, and K. D. Janda (2002)
PNAS
99, 2648-2653
| Abstract »
| Full Text »
| PDF »
- Synthesis of an organoinsulin molecule that can be activated by antibody catalysis.
- D. S. Worrall, J. E. McDunn, B. List, D. Reichart, A. Hevener, T. Gustafson, C. F. Barbas III, R. A. Lerner, and J. M. Olefsky (2001)
PNAS
| Abstract »
| Full Text »
| PDF »
- Observation of Covalent Intermediates in an Enzyme Mechanism at Atomic Resolution.
- A. Heine, G. DeSantis, J. G. Luz, M. Mitchell, C.-H. Wong, and I. A. Wilson (2001)
Science
294, 369-374
| Abstract »
| Full Text »
| PDF »
- In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy.
- D. Shabat, H. N. Lode, U. Pertl, R. A. Reisfeld, C. Rader, R. A. Lerner, and C. F. Barbas III (2001)
PNAS
| Abstract »
| Full Text »
| PDF »
- Covalent intermediate trapped in 2-keto-3-deoxy-6- phosphogluconate (KDPG) aldolase structure at 1.95-A resolution.
- J. Allard, P. Grochulski, and J. Sygusch (2001)
PNAS
98, 3679-3684
| Abstract »
| Full Text »
| PDF »
- Overpassing an aberrant V{kappa} gene to sequence an anti-idiotypic abzyme with {beta}-lactamase-like activity that could have a linkage with autoimmune diseases.
- H. DEBAT, B. AVALLE, O. CHOSE, C.-O. SARDE, A. FRIBOULET, and D. THOMAS (2001)
FASEB J
15, 815-822
| Abstract »
| Full Text »
| PDF »
- Three-Dimensional Structure of the Fab from a Human IgM Cold Agglutinin.
- A. Cauerhff, B. C. Braden, J. G. Carvalho, R. Aparicio, I. Polikarpov, J. Leoni, and F. A. Goldbaum (2000)
J. Immunol.
165, 6422-6428
| Abstract »
| Full Text »
| PDF »
- Structural evidence for a programmed general base in the active site of a catalytic antibody.
- B. Golinelli-Pimpaneau, O. Goncalves, T. Dintinger, D. Blanchard, M. Knossow, and C. Tellier (2000)
PNAS
97, 9892-9895
| Abstract »
| Full Text »
| PDF »
- Using antibody catalysis to study the outcome of multiple evolutionary trials of a chemical task.
- A. Karlstrom, G. Zhong, C. Rader, N. A. Larsen, A. Heine, R. Fuller, B. List, F. Tanaka, I. A. Wilson, C. F. Barbas III, et al. (2000)
PNAS
97, 3878-3883
| Abstract »
| Full Text »
| PDF »
- Multiple event activation of a generic prodrug trigger by antibody catalysis.
- D. Shabat, C. Rader, B. List, R. A. Lerner, and C. F. Barbas III (1999)
PNAS
96, 6925-6930
| Abstract »
| Full Text »
| PDF »
- Aldol sensors for the rapid generation of tunable fluorescence by antibody catalysis.
- B. List, C. F. Barbas III, and R. A. Lerner (1998)
PNAS
95, 15351-15355
| Abstract »
| Full Text »
| PDF »
- Bringing biological solutions to chemical problems.
- P. G. Schultz (1998)
PNAS
95, 14590-14591
| Full Text »
| PDF »
- The antibody catalysis route to the total synthesis of epothilones.
- S. C. Sinha, C. F. Barbas III, and R. A. Lerner (1998)
PNAS
95, 14603-14608
| Abstract »
| Full Text »
| PDF »
- C5 Convertase of the Alternative Pathway of Complement. KINETIC ANALYSIS OF THE FREE AND SURFACE-BOUND FORMS OF THE ENZYME.
- N. Rawal and M. K. Pangburn (1998)
J. Biol. Chem.
273, 16828-16835
| Abstract »
| Full Text »
| PDF »
- A Catalytic Antibody Produces Fluorescent Tracers of Gap Junction Communication in Living Cells.
- M. C. Subauste, B. List, X. Guan, K. M. Hahn, R. Lerner, and N. B. Gilula (2001)
J. Biol. Chem.
276, 49164-49168
| Abstract »
| Full Text »
| PDF »
- In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy.
- D. Shabat, H. N. Lode, U. Pertl, R. A. Reisfeld, C. Rader, R. A. Lerner, and C. F. Barbas III (2001)
PNAS
98, 7528-7533
| Abstract »
| Full Text »
| PDF »
- Synthesis of an organoinsulin molecule that can be activated by antibody catalysis.
- D. S. Worrall, J. E. McDunn, B. List, D. Reichart, A. Hevener, T. Gustafson, C. F. Barbas III, R. A. Lerner, and J. M. Olefsky (2001)
PNAS
98, 13514-13518
| Abstract »
| Full Text »
| PDF »
|
|